We are thrilled to be named as finalists for the Vesalius Innovation Award by Karger Publishers. This award celebrates innovation with a focus on publishing in early stage health science companies, taking its name and inspiration from the surgeon Vesalius who revolutionised anatomy nearly 500 years ago.
So, what does innovation mean to CiteAb? Our founder, Dr Andrew Chalmers, reflected: “Innovation is at the heart of what we do at CiteAb and we are always looking for new ways to help researchers and their suppliers to ultimately accelerate science. We were very excited, therefore, to be named as a finalist for this award.”
CiteAb innovates in many ways, including launching new products and improving existing ones as well as constantly developing new tech to support our collection of high quality data.
Over the past year, we have introduced experimental models – which includes cells, tissues, lysates and animals – into our product line up. In response to the COVID-19 pandemic, we secured Innovate UK funding to develop our existing AI platform to include a COVID-19 research reagent tool. Looking forward, our team is working hard to launch the addition of citations from preprints early next year.
Finally, we would like to give a nod to our fellow finalists and innovators, who we are proud to be shortlisted with:
Appsens: a medical technology company who created a wireless heart monitoring device
Nested Knowledge: a software company transforming the process of systematic reviews and meta analyses for researchers
Pilloxa: a technology company involved in the creation of living mobile applications to assist and learn from patients
Sorcero: a technology company who built a language intelligence platform to understand scientific text at scale
The next stage in our awards journey is the final pitch on October 18th as part of the Frankfurt book fair. Winners will then be announced in December, so keep an eye on our social channels for more updates!
- Skye and the CiteAb team